Applications of a salt tolerant cation exchanger carrying sulfate groups
- Egbert Müller,
- Djuro Josic,
- Marija Begic,
- Suzana Pecenkovic,
- Uros Andjelkovic
Egbert Müller
Tosoh Bioscience GmbH
Corresponding Author:egbert.mueller@tosoh.com
Author ProfileDjuro Josic
Warren Alpert Medical School of Brown University
Author ProfileAbstract
Difference between two strong cation-exchange resins, namely sulfonium
type and sulfate type regarding both their salt tolerance and
hydrophobicity were investigated. There is only tiny variation between
sulfate and sulfonic group and at the first glance it seems unlikely
that it could be the reason for changed selectivity and salt tolerance
that was detected in our preliminary experiments. For that reason salt
tolerance and hydrophobicity of both ligands was investigated by using
two representative polymethacrylate-based ion exchangers as for the
sulfonium type TOYOPEARL GigaCap S-650M and for the sulfate type
TOYOPEARL Sulfate-650F. In addition some in-silico calculations were
performed for model substances representing the sulfonium and sulfate
group, and significant differences were calculated regarding their
hydrophobicity. These experiments confirmed the working hypothesis that
salt tolerance and higher affinity and selectivity for some human plasma
derived vitamin K dependent clotting factors and inhibitors are
interrelated and dependent from the presence of the sulfate group. The
affinity for these proteins was experimentally verified by separation of
clotting factor IX from the prothrombin complex concentrate. Presented
results show that a simple and fast separation between clotting factor
IX and other vitamin K dependent clotting factors II, VII and X is
possible, only if the resin with the sulfate, and not with sulfonic acid
ligand was applied. Consequently, an immediate application of undiluted
feedstock or the eluate from previous isolation step to sulfate resin is
possible, and a significant optimization of downstream process can be
achieved.24 Feb 2021Submitted to Biotechnology Journal 24 Feb 2021Submission Checks Completed
24 Feb 2021Assigned to Editor
24 Feb 2021Reviewer(s) Assigned
24 Mar 2021Editorial Decision: Revise Major
03 Jun 20211st Revision Received
07 Jun 2021Submission Checks Completed
07 Jun 2021Assigned to Editor
07 Jun 2021Reviewer(s) Assigned
24 Jun 2021Editorial Decision: Revise Minor
25 Jun 20212nd Revision Received
28 Jun 2021Submission Checks Completed
28 Jun 2021Assigned to Editor
28 Jun 2021Reviewer(s) Assigned
30 Jun 2021Editorial Decision: Revise Minor
01 Jul 20213rd Revision Received
05 Jul 2021Submission Checks Completed
05 Jul 2021Assigned to Editor
16 Jul 2021Editorial Decision: Accept